Go to Client Portal
NAMSA

NAMSA ACQUIRES EUROPEAN-BASED MEDANEX CLINIC TO EXPAND EARLY-STAGE PRECLINICAL RESEARCH CAPABILITIES

NAMSA announced today its nearing acquisition of Medanex Clinic, a Belgium-based European preclinical research organization. Medanex’s robust preclinical capabilities and expertise, specifically in the Cardiovascular arena, will help enhance NAMSA capabilities and over Client experience.

Incorporating CT Imaging into Preclinical Studies

Identifying the right model for a preclinical study can be a significant challenge. The choice often comes down to whether the model shares specific anatomical characteristics with the humans who will eventually be the end users of a particular medical device. Another consideration is the size of the model and how it accommodates a specific medical device.

NAMSA Acquires American Preclinical Services

NAMSA, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today its acquisition of Minneapolis-based American Preclinical Services (APS), a full service preclinical CRO. This purchase follows NAMSA’s acquisition of New York-based Syntactx, a leading clinical research services CRO, in January 2021.